Adma Biologics, Inc. SEC filings ADMA
Adma Biologics, Inc. has 999 filings in SEC EDGAR's recent list, going back to Jul 10, 2006. Its latest annual report, Form ARS, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Dec 7, 2022 | — |
| 424B5 | Prospectus supplement | Dec 6, 2022 | — |
| S-8 POS | Filing | Jul 22, 2022 | — |
| S-8 POS | Filing | Jul 22, 2022 | — |
| S-8 POS | Filing | Jul 22, 2022 | — |
| S-8 POS | Filing | Jul 22, 2022 | — |
| S-8 POS | Filing | Jul 22, 2022 | — |
| S-8 POS | Filing | Jul 22, 2022 | — |
| S-8 POS | Filing | Jul 22, 2022 | — |
| S-8 | Employee stock plan registration | Jul 22, 2022 | — |
| S-8 | Employee stock plan registration | Mar 7, 2022 | — |
| 424B5 | Prospectus supplement | Oct 21, 2021 | — |
| 424B5 | Prospectus supplement | Oct 20, 2021 | — |
| 424B5 | Prospectus supplement | Sep 3, 2021 | — |
| S-3/A | Filing | Aug 3, 2021 | — |
| S-3 | Shelf registration | May 28, 2021 | — |
| S-8 | Employee stock plan registration | Mar 26, 2021 | — |
| 424B5 | Prospectus supplement | Feb 3, 2021 | — |
| 424B5 | Prospectus supplement | Nov 5, 2020 | — |
| 424B5 | Prospectus supplement | Aug 5, 2020 | — |
| S-8 | Employee stock plan registration | Apr 13, 2020 | — |
| 424B5 | Prospectus supplement | Feb 7, 2020 | — |
| 424B5 | Prospectus supplement | Feb 6, 2020 | — |
| 424B7 | Filing | Oct 7, 2019 | — |
| S-3 | Shelf registration | Oct 4, 2019 | — |
| 424B5 | Prospectus supplement | May 17, 2019 | — |
| 424B5 | Prospectus supplement | May 15, 2019 | — |
| S-8 | Employee stock plan registration | Feb 27, 2019 | — |
| 424B5 | Prospectus supplement | Jun 8, 2018 | — |
| 424B5 | Prospectus supplement | Jun 7, 2018 | — |
| S-3/A | Filing | May 29, 2018 | — |
| S-3 | Shelf registration | May 18, 2018 | — |
| S-8 | Employee stock plan registration | Apr 27, 2018 | — |
| 424B1 | Filing | Nov 9, 2017 | — |
| S-1MEF | Filing | Nov 8, 2017 | — |
| S-1/A | Amended registration statement | Nov 8, 2017 | — |
| S-1/A | Amended registration statement | Nov 3, 2017 | — |
| S-1/A | Amended registration statement | Oct 23, 2017 | — |
| S-1 | Registration statement | Oct 11, 2017 | — |
| S-8 | Employee stock plan registration | Aug 18, 2017 | — |
| S-3 | Shelf registration | Jun 16, 2017 | — |
| 424B5 | Prospectus supplement | Apr 28, 2016 | — |
| 424B5 | Prospectus supplement | Apr 27, 2016 | — |
| S-8 | Employee stock plan registration | May 29, 2015 | — |
| 424B5 | Prospectus supplement | Mar 13, 2015 | — |
| 424B5 | Prospectus supplement | Mar 12, 2015 | — |
| S-3/A | Filing | Dec 22, 2014 | — |
| S-3 | Shelf registration | Nov 28, 2014 | — |
| S-8 | Employee stock plan registration | Jan 29, 2014 | — |
| 424B4 | Prospectus | Oct 17, 2013 | — |
| S-1/A | Amended registration statement | Oct 4, 2013 | — |
| S-1/A | Amended registration statement | Sep 25, 2013 | — |
| S-1/A | Amended registration statement | Apr 30, 2013 | — |
| S-1/A | Amended registration statement | Apr 22, 2013 | — |
| S-1/A | Amended registration statement | Apr 8, 2013 | — |
| S-1 | Registration statement | Feb 11, 2013 | — |
| 424B3 | Prospectus | Aug 17, 2012 | — |
| S-1/A | Amended registration statement | Aug 13, 2012 | — |
| S-1/A | Amended registration statement | Aug 10, 2012 | — |
| S-1/A | Amended registration statement | Jul 3, 2012 | — |
| S-1/A | Amended registration statement | Jun 5, 2012 | — |
| S-1/A | Amended registration statement | May 8, 2012 | — |
| S-1 | Registration statement | Mar 29, 2012 | — |
Showing 63 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ADMA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Ramsey, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1368514
- Former names
- R&R ACQUISITION VI, INC (until Feb 21, 2012)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.